All documents for Covaxin emergency use listing submitted to WHO, expect approval at earliest: Bharat BiotechAccording to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public hea...
Abbott launches COVID-19 home test kit in IndiaIn alignment with the current ICMR advisory on self-use, these tests will be made available to ramp up testing of symptomatic and asymptoma...
Govt should take decisive actions to ramp up COVID vaccines production: Apollo Hospitals Group Joint MD Sangita Reddy"I urge @PMOIndia 2 take Bold & decisive actions to ramp up #COVID #vaccines & streamline inoculation processes to include citizens who do ...
COVID-19: HMD to recruit 500 people to increase syringe production capacity"We currently have extreme shortages of manpower. To reach our target of 100 crore syringes capacity, HMD needs to strengthen our team and ...
Natco Pharma forays into pheromone-based technology for integrated pest management"During Kharif 2021, NATCO plans to launch its first green label pheromone product for effective management of Pink Bollworm (PBW) in cotto...
AstraZeneca Pharma India Q1 results: Net profit declines 13% at Rs 18.63 croreDrug firm AstraZeneca Pharma India on Monday reported a 13.38 per cent decline in its net profit to Rs 18.63 crore for the quarter ended Ju...
Wockhardt gets QIDP designation from USFDA for its combination antibioticThe QIDP status is granted to drugs that are effective against a set of multi-drug resistant pathogens identified by the Centre for Disease...
Extension of lockdown right decision amid spiking Covid-19 cases: Kiran Mazumdar-Shaw"The extension of pan-India lockdown till May 3, 2020, is an important and right decision taken by the Prime Minister. India is registering...
Working with govt, key stakeholders to ensure continued supply of medicines: IPAThe Indian Pharmaceutical Alliance (IPA) and various pharma industry associations in India and other key stakeholders in the pharmaceutical...
Yes Bank reduces stake in Fortis Healthcare by 2%Yes Bank sold 1,51,06,283 equity shares of the company.
Novartis India Q4 profit falls 26% to Rs 20 croreRevenue from operations for the latest quarter stood at Rs 110.38 crore as against Rs 125.32 crore in the same period of 2017-18.
Biocon gets 6 observations from USFDA after inspection of its Bengaluru plantBiocon is confident of addressing these expeditiously and remains committed to global standards of quality and compliance, the statement ad...
Wockhardt sets up its first manufacturing facility in Middle East"With the new facility in the Middle East, we aim to focus on our commitment to developing NCEs to fight the health issues," Wockhardt Foun...
Glenmark gets USFDA nod for psoriasis sprayGlenmark Pharmaceuticals Inc, USA has received final approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propio...
NPPA fixes retail price of 5 formulationsThe national Pharmaceutical Pricing Authority (NPPA) has also revised the ceiling price of Metronidazole injection used for treatment of th...
GSK Pharma completes deal with Novartis HealthcareDrug firm GlaxoSmithKline Pharmaceuticals has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis...
Typhoid control key to prevent gallbladder cancer in IndiaThe findings establish for the first time the causal link between bacterial infection and gallbladder cancer.